Alerje Press and Newsroom

Wondering what's new in the Alerje world? Get the scoop on our latest food allergy product updates, news coverage, features, promotions and more in our Newsroom.

Most Recent

Alerje Joins StartUp Health's California Health Care Foundation Cohort!

Alerje is proud to be one of the first five companies to join StartUp Health’s California Health Care Foundation Cohort. As a member of the StartUp Health portfolio, Alerje is thrilled to be a part of this 12-month cohort focused on health equity, addressing missed opportunities for new products and services to solve problems such as food allergies and improve lives.

View More
INTRODUCING: The Smart Defenders Comic Series!

Introducing The Smart Defenders, an illustrated comic series and resource to inspire families managing food allergies and oral immunotherapy. From the initial reaction to OIT, catch the adventures of Myles Jasper Smart, III, and the lovable Smart Family as they navigate food allergy surprises, battles, and triumphs!

View More
A photo of a little boy wearing blue glasses, Myles Jasper Smart, from the Smart Defenders Comic Series.
Alerje at MIT's Sloan Healthcare and BioInnovations Conference (SHBC)

We're excited to be represented at the Michigan Institute of Technology! Our CEO Javier Evelyn will represent Alerje at the MIT Sloan Healthcare and BioInnovations Conference (SHBC) on April 1st, 2022 to discuss Alerje's perspective on how we use technology to create a more equitable/engaging food allergy patient experience and more.

View More
Illinois State Article Feature: Turning an Allergy into Alerje Inc

Alerje's CEO, Javier Evelyn '06, was featured in Illinois State University's "Javier Evelyn: Turning an Allergy into Alerje Inc." As a fellow ISU alumnus, read Javier's story as well as the inspiration behind Alerje's work to make a difference in the lives of patients and caregivers impacted by life-threatening food allergies.

View More
Screenshot of Article Feature from Illinois State University, featuring Alerje's CEO Javier Evelyn standing by a desk, accompanied by the Alerje logo in the background.
Alerje Featured in the Free-From Magazine

EXTRA EXTRA! Alerje is featured in Food Equality Initiative's award-winning Free-From Magazine! Learn about our story, developments such as the Omniject™ to our work with the NSF. PLUS, our team members' commitment to improving the lives of food allergy families. Check it out in the Jan-Feb 2022 issue.

View More
Solidea Capital Article Feature: Transforming an Industry

Alerje's CEO Javier Evelyn was featured in an article for Solidea Capital! From epinephrine storage to easing OIT and food allergy therapies, read how CEO Javier Evelyn's personal struggle with food allergies and key partners such as Solidea have inspired Alerje's work to transform lives.

View More
Alerje featured in FARE's Take Action! with Hillary Tolle Carter

Alerje's CEO Javier Evelyn is featured in an episode of Food Allergy Research and Education's Take Action! with Hillary Tolle Carter. Topics include our upcoming innovations in food allergy such as our Omniject smartphone-attached auto-injector, OIT Management Platform, and our current lifestyle mobile app.

View More
Alerje CEO Wins Salute Award at Tech Town Detroit

Congratulations to Alerje's CEO Javier Evelyn on receiving the Salute Award yesterday for his excellence in entrepreneurship as well as Alerje's work and continuous innovation to help those with food allergies Make Every Moment Count. Check it out below at the 1:07:45 Mark.

View More
PAID STUDY: Alerje NSF Study On Oral Immunotherapy (OIT)

In case you missed it, Alerje received a grant from the National Science Foundation. As a result, Alerje has a paid study opportunity for families and individuals currently taking Oral Immunotherapy (OIT) for food allergies. Check out the link below to sign up or for more information! Deadline: 2/18/22

View More
Alerje in The Detroit News

Alerje is pleased to have been featured in Detroit News! From our founder and CEO Javier Evelyn's personal struggle with food allergies to our upcoming Omniject smartphone-attached epinephrine auto-injector, we are thrilled to have Alerje's work featured and are excited for what's to come.

View More
StartUpHealth: 12 Startups Ensuring Every Child Has Access to Quality Care

Alerje is proud to be in StartUpHealth's list of 12 Startups Ensuring Every Child Has Access to Quality Care! Read about our "Treatment x Lifestyle" approach to designing technology to improve the lives and safety of children with food allergies, including our Omniject epinephrine auto-injector in development.

View More
CEO Javier Evelyn on the MM+M Podcast

Alerje is pleased to be featured on Medical Marketing + Media Podcast! Our CEO Javier Evelyn goes in depth on his personal struggle with food allergies, Alerje's lifestyle app and details on upcoming products such as the Omniject™ smartphone-attached epinephrine auto-injector and OIT Adherence platform with host Marc Iskowitz.

View More
Best Food Allergy Apps 2021

Woohoo! Grateful to have the Alerje app featured as one the best Food Allergy Apps in 2021 by My Allergy Kitchen! Alerje is proud to be creating resources that simplify Food Allergy Management and help families Make Every Moment count.

View More
Alerje Announces Phase 1 SBIR Grant Award From The National Science Foundation

We're thrilled to share that Alerje has been granted a Phase I SBIR grant from the National Science Foundation (NSF)! This award will center around Alerje's patent pending Food Allergy Oral Immunotherapy digital adherence platform.

View More
Alerje Featured in Allergic Living Magazine

EXTRA, EXTRA! Check out Alerje's feature in Allergic Living's Summer E-Magazine, "Our Stories, Our Strength." Read Alerje's CEO Javier Evelyn's story of courage through multiple food allergies guided his career in technology as well as other incredible stories of the food allergy community in this edition of Allergic Living.

View More
Alerje Announces Granted Patent for an Epinephrine Auto-Injector for Smartphones

When seconds count, Alerje's Omniject is a smartphone case that houses an auto-injector, ensuring that caregivers can quickly access Epinephrine during severe reactions.

View More
Introducing the Inaugural Alerje Medical Advisory Board

Over the past year, our company has evolved for the better. While we've been incredibly fortunate to have been supported by, or supporters of key clinical stakeholders, we understood that this was an area we wanted internal support from. Alerje is pleased to announce our inaugural Medical Advisory Board!

View More
Alerje on Shandeeland Podcast

Alerje's CEO Javier Evelyn discusses his journey from being a food allergy patient to developing innovative technology to help families Make Every Moment Count. Find out the biggest reasons why people aren’t carrying their prescribed epinephrine and how Alerje is committed to developing a more convenient solution.

View More
Ready, Set, Food! Live Panel: Innovation and New Guidelines in Pediatric Food Allergy

Alerje's CEO joined an exciting live panel to discuss new food allergy guidelines and innovations within pediatric food allergy alongside experts from Mark Cuban-backed Ready, Set, Food!, Allison Rose Foundation, Food Allergy Fund, Northwestern University, Children's Hospital of Philadelphia, and more!

View More
Alerje on FAACT Roundtable Podcast!

In this can't-miss discussion, FAACT sits down with Alerje's CEO, Javier Evelyn, to learn more about how innovation is pushing forward new discoveries to improve the quality of life for people living with food allergies through digital health technology on Ep. 38: Food Allergy Treatment and Lifestyle - Getting to Know Alerje.

View More
Google For Startups Supports Alerje via Black Founders Fund

We’re proud of the work we’re doing and excited to share that we’ve been honored as a Google for Startups Black Founders Fund recipient. With funding and support, we’re one step closer to leveling the playing field and making the startup ecosystem a more equitable and brilliant community. Read more about this opportunity below!

View More
Alerje Accepted into StartUp Health

StartUp Health, one of the top names in Digital Health. StartUp Health focuses on health innovation and categorizes by 12 health moonshots to invest in. Their portfolio companies have collectively raised nearly $1.7B, while 7.7% of their companies have been acquired. This only scratches the surface of the many reasons why we're thrilled to have them onboard! Special thanks to our advisor Dr. Sabine Seymour for making this introduction!

View More
Alerje Selected as Semi-Finalist for Detroit Demo Day

On October 20th 2020, we'll be competing for our share of around $1M in prizes! Alerje was selected as one of 17 companies from over 100 entries as a semi-finalist for one of the top pitch competitions in the Midwest. Additionally, the public will be able to vote on three People's Choice Grants.

View More
Alerje Joins the Inaugural Backstage Capital Accelerator!

We're happy to announce that Alerje has been accepted into the inaugural Backstage Accelerator cohort in Detroit! There were over 1,800 applications from around the world, with an acceptance rate of less than 2%, and we're honored to be a part of such an awesome program!

View More
FDA Backed Startup Program Accepts Alerje

The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) is an FDA funded MedTech accelerator supporting pediatric device innovators from concept to commercialization. As a CTIP portfolio member, Alerje is connected to a national network of clinical, scientific, regulatory, as well as business experts.

View More
MedTech Startup Alerje Uses Patient Design to Create Allergy Medicine Device

We recently came across this wonderful article on Alerje by Shavaughn Baker of The Corporate Concierge Group. Read about our Proactive Patient Driven Design approach and more!

View More
MedTech Founders Panel at Detroit Startup Week

On behalf of Alerje, Javier joined some of Michigan's emerging entrepreneurs in the Health and Wellness, Life Sciences, and Medical Innovation space. We discussed opportunities, identified growth challenges, and swapped success stories at every stage of startup development.

View More
MedTech Innovator Pitch Competition

Earlier this month, Alerje was one of 8 companies selected for the 2018 MedTech Innovator Chicago Regional Pitch Competition. We had the opportunity to present to and receive feedback from judges including investors, providers, and senior executives from leading medtech companies such as Johnson & Johnson, Baxter, Molex, and many others. Based on feedback, there's a chance that we could be selected to advance to participate in the MedTech Innovator Accelerator and/or Showcase Program. Alerje happened to place in the top 3 at this event, so we're hopeful we'll be given the opportunity to move forward!

View More
Alerje Brings On Former Pharmaceutical Exec to the Team

Frank Orlowski brings over a decade of experience in the pharmaceutical industry to Alerje as an investor and strategic advisor.

View More
Food Allergy Advocacy at Nashville Sounds and University of Michigan Mary H. Weiser Food Allergy Center

Alerje was showcased at the Nashville Sounds "Peanut Free Night", sharing our vision with over 7,000 attendees! We're thankful for The Allergy, Asthma, & Sinus Center as well as another one of our awesome advisors, Dr. Robert Moskowitz, for the opportunity! Next, we were proud to support the 4th annual University of Michigan Mary H. Weiser Food Allergy Center Spring Luncheon. The luncheon benefits a mission of improving the lives of food allergic individuals by conducting comprehensive research that will significantly improve patient care and expand food allergy education, research and community services. Both events gave us incredible insight and feedback from some of our most key stakeholders, patients, providers, and a few payers. Alerje was well received!

View More